YLR456W Antibody

Shipped with Ice Packs
In Stock

Description

Overview of YLR456W Antibody

YLR456W is a gene identifier in Saccharomyces cerevisiae (yeast), where "YLR" denotes its chromosomal location (left arm of chromosome XII), "456" is its open reading frame (ORF) number, and "W" indicates its orientation on the Watson strand. The YLR456W antibody is a research tool developed to detect and study the protein product of this gene. While limited direct studies on this specific antibody exist, insights can be extrapolated from antibody engineering principles and yeast genomic research .

Functional Role of YLR456W in Yeast

YLR456W is implicated in DNA damage response (DDR) pathways. Key findings include:

  • Genetic Interactions: YLR456W deletion mutants overlap with genes associated with sensitivity to DNA-damaging agents, chromosomal loss, and telomere maintenance .

  • Phenotypic Correlations: A Pearson correlation analysis linked YLR456W to foci formation (a marker of DNA repair activity) and physiological stress responses .

Table 1: Functional Annotations of YLR456W

FeatureDescriptionSource
Chromosomal LocationXII (Left Arm)
Biological ProcessDNA repair, telomere maintenance
Mutant PhenotypeIncreased Rad52-YFP foci (DNA repair foci)

Antibody Development and Applications

While no explicit data on YLR456W antibody production exists in the provided sources, general antibody engineering principles apply:

  • scFv Antibodies: Single-chain variable fragments (scFv) are commonly used for yeast protein detection due to their small size and compatibility with bacterial expression systems .

  • Structural Optimization: Techniques like inverse folding (e.g., AntiFold model) improve antibody stability and binding affinity, which could enhance YLR456W detection .

Research Gaps and Challenges

  • Limited Direct Studies: The provided sources lack explicit references to YLR456W antibody development or validation.

  • Epitope Characterization: The target epitope of YLR456W remains uncharacterized, necessitating further structural studies .

Future Directions

  • Database Mining: Proteomic databases (e.g., OAS, UniProt) could identify YLR456W-derived peptides for antibody validation .

  • Functional Assays: Pairing YLR456W antibodies with Rad52-YFP foci assays would clarify its role in DDR .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR456W antibody; Pyridoxamine 5'-phosphate oxidase YLR456W homolog antibody; PNP/PMP oxidase YLR456W homolog antibody; PNPOx YLR456W homolog antibody
Target Names
YLR456W
Uniprot No.

Target Background

Gene References Into Functions
  1. Does not function as a pyridoxamine 5'-phosphate oxidase. PMID: 26327315
Database Links

KEGG: sce:YLR456W

STRING: 4932.YLR456W

Protein Families
Pyridoxamine 5'-phosphate oxidase family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is YLR456W and why is it important to study?

YLR456W is a poorly characterized protein in Saccharomyces cerevisiae (budding yeast) that has been implicated in meiotic cell division processes based on transcriptional profiling and functional genomics studies. The importance of studying this protein stems from its potential role in fundamental cellular processes during meiosis, which could provide insights into conserved mechanisms of cell division. Transcriptional studies have highlighted YLR456W as potentially significant in yeast reproductive processes, specifically during sporulation and meiotic division . Developing specific antibodies against this protein allows researchers to track its expression, localization, and interactions throughout the cell cycle, providing crucial insights into its function.

What validation methods should be used to confirm YLR456W antibody specificity?

Validation of YLR456W antibodies requires a multi-faceted approach centered on knockout controls. The gold standard involves performing Western blot analysis comparing wild-type yeast cell lysates with YLR456W knockout strains. A specific antibody will show bands only in the wild-type lane and absence of signal in the knockout sample . Secondary validation should include immunoprecipitation followed by mass spectrometry identification of pulled-down proteins. For immunofluorescence applications, parallel staining of wild-type and knockout strains is essential, with the knockout strain showing minimal to no signal. Additionally, researchers should perform epitope mapping to confirm the antibody binds to the intended region of YLR456W, particularly important given the limited characterization of this protein.

How should researchers interpret multiple bands when using YLR456W antibodies in Western blots?

When Western blots display multiple bands using YLR456W antibodies, researchers should systematically evaluate several possibilities before concluding antibody non-specificity. Multiple bands may represent:

  • Different post-translational modifications of YLR456W

  • Splice variants or truncated forms of the protein

  • Proteolytic degradation products

  • Multimeric forms of the protein

  • Non-specific binding to other proteins

To distinguish between these possibilities, researchers should:

  • Compare band patterns with predicted molecular weights of known isoforms

  • Perform targeted knockout/knockdown experiments

  • Use denaturing vs. non-denaturing conditions to identify multimeric forms

  • Employ different lysis buffers with varying protease inhibitor compositions to assess degradation

  • Consider phosphatase treatments to identify phosphorylated forms

A selective antibody might display multiple wild-type bands representing these various forms of YLR456W . Complete absence of all bands in knockout controls provides the strongest evidence for specificity despite multiple bands.

How can YLR456W antibodies be incorporated into high-throughput phenotypic screens of yeast mutants?

Incorporating YLR456W antibodies into high-throughput phenotypic screens requires careful experimental design and automation. Researchers can develop systematic approaches similar to the quantitative yeast phenomics methods described in literature . The protocol would involve:

  • Generate a collection of yeast strains with different genetic backgrounds (deletion mutants of interest)

  • Grow strains under various conditions that might induce meiosis or stress responses

  • Perform automated immunostaining with YLR456W antibodies coupled with high-content imaging

  • Quantify YLR456W protein levels, localization patterns, and potential post-translational modifications

  • Correlate these measurements with phenotypic outcomes using machine learning algorithms

This approach allows for identification of genes that functionally interact with YLR456W, particularly those involved in DNA damage response pathways. Previous screens have shown significant overlap between deletion mutants sensitive to DNA-damaging agents and those with altered meiotic protein expression . For YLR456W specifically, researchers might identify novel genetic interactions that explain its role in meiotic cell division.

What are the optimal conditions for using YLR456W antibodies in chromatin immunoprecipitation (ChIP) experiments?

Optimizing ChIP protocols for YLR456W antibodies requires careful consideration of several parameters specific to yeast chromatin structure and protein-DNA interactions:

  • Crosslinking optimization: Test both formaldehyde (1-3%) and dual crosslinking methods (formaldehyde plus EGS/DSG) with varying incubation times (10-30 minutes)

  • Chromatin fragmentation: Optimize sonication parameters for yeast cells, targeting fragment sizes of 200-500bp

  • Antibody selection: Compare different epitope targets (N-terminal vs. C-terminal) for YLR456W antibodies

  • IP conditions: Test various buffer compositions and incubation times to reduce background

  • Controls: Include:

    • Input chromatin (pre-IP sample)

    • IgG control (non-specific antibody)

    • YLR456W knockout strain

The protocol should be adjusted based on current understanding of YLR456W's potential role in meiotic processes. If YLR456W interacts with DNA during specific cell cycle phases, synchronizing yeast cultures before harvesting is essential. Researchers have successfully used similar approaches for studying Ume6-dependent gene expression during yeast sporulation , and these techniques can be adapted for YLR456W studies.

What strategies can be employed to develop multispecific antibodies that recognize both YLR456W and related proteins?

Developing multispecific antibodies targeting YLR456W and related proteins can leverage engineering approaches similar to those used for therapeutic antibodies. Based on current antibody engineering technologies, researchers can consider:

  • Bispecific antibody (bsAb) design: Create scFv-Ig format antibodies where one specificity targets YLR456W and another targets a related protein of interest. Various fusion formats can be tested:

    • Heavy chain C-terminus fusion (scAb-YLR456W HCC)

    • Light chain N-terminus fusion (scAb-YLR456W LCN)

    • Light chain C-terminus fusion (scAb-YLR456W LCC)

  • Trispecific antibody (tsAb) development: For more complex studies requiring monitoring of three proteins simultaneously, trispecific antibodies can be engineered using scFv-scFv-IgG fusion approaches . This is particularly valuable for tracking protein complexes during meiosis.

  • Expression and purification: Optimize expression in Freestyle™-293F suspension-adapted human embryonic kidney cells and purification using protein A affinity columns .

  • Validation: Employ biolayer interferometry (BLI) using the OctetRed™ system to determine binding properties, including association rate constants (kon), dissociation rate constants (koff), and equilibrium dissociation constants (KD) .

These approaches allow for simultaneous monitoring of YLR456W and its interaction partners in complex cellular processes, providing insights into protein network dynamics during meiosis.

What fixation and permeabilization methods are optimal for detecting YLR456W using immunofluorescence in yeast cells?

Optimal detection of YLR456W via immunofluorescence requires careful consideration of yeast cell wall properties and protein localization:

Fixation MethodConcentrationDurationBest For
Formaldehyde3.7-4%30-60 minGeneral protein detection
Methanol/Acetone (1:1)100%5 min at -20°CNuclear proteins
Combined formaldehyde/methanol3.7%/100%30 min/5 minMembrane-associated proteins

For permeabilization, researchers should consider:

  • Enzymatic cell wall digestion: Use Zymolyase (100T at 0.5-1 mg/ml) for 30 minutes at 30°C to create spheroplasts

  • Detergent treatment: Following fixation and cell wall digestion, use:

    • 0.1% Triton X-100 for cytoplasmic proteins

    • 0.5% Saponin for membrane proteins

    • 0.1% SDS for nuclear proteins (including potential transcription factors)

The method selection should be guided by the hypothesized subcellular localization of YLR456W. Based on its potential role in meiotic division , researchers should initially test protocols optimized for nuclear and spindle-associated proteins. For all conditions, parallel processing of YLR456W knockout strains is essential to establish specificity. This approach mirrors the immunofluorescence validation techniques used by YCharOS for antibody characterization .

How should researchers troubleshoot weak or variable immunoprecipitation results with YLR456W antibodies?

When troubleshooting weak or variable immunoprecipitation results with YLR456W antibodies, researchers should implement a systematic optimization strategy:

  • Antibody quality assessment:

    • Validate the antibody using Western blot with knockout controls

    • Test different antibody concentrations (1-10 μg per IP)

    • Compare different antibody clones targeting different epitopes

  • Lysis and buffer optimization:

    • Test different lysis buffers (RIPA, NP-40, Triton X-100)

    • Optimize salt concentration (150-500 mM NaCl)

    • Adjust detergent type and concentration

    • Ensure complete protease inhibitor cocktail inclusion

  • IP conditions:

    • Compare various bead types (Protein A/G, magnetic vs. agarose)

    • Test pre-clearing of lysates to reduce background

    • Optimize incubation times (2 hours vs. overnight)

    • Consider crosslinking antibodies to beads to prevent antibody contamination

  • Cell culture conditions:

    • Synchronize yeast cultures to enrich for meiotic phases

    • Test different growth media and stress conditions

    • Consider cell density and growth phase

  • Experimental controls:

    • Include IgG control IP

    • Process YLR456W knockout samples in parallel

    • Use positive control IPs with well-characterized abundant proteins

For challenging targets like YLR456W, researchers might need to consider more specialized approaches such as proximity-dependent biotin labeling (BioID) as an alternative to traditional IP methods. The BioID approach can be particularly useful for detecting transient or weak interactions during specific meiotic phases.

What are the most reliable epitope regions of YLR456W for antibody development?

Developing antibodies against optimal epitopes of YLR456W requires careful sequence analysis and consideration of protein structure:

  • Sequence analysis for epitope prediction:

    • Analyze hydrophilicity, surface accessibility, and antigenicity profiles

    • Avoid regions with high sequence conservation across related proteins unless cross-reactivity is desired

    • Identify unique regions that distinguish YLR456W from other yeast proteins

  • Structural considerations:

    • Target regions predicted to be surface-exposed in the native protein

    • Avoid transmembrane domains or highly hydrophobic regions

    • Consider regions that undergo minimal post-translational modifications

  • Recommended epitope regions:

    • N-terminal region (if unique): Good for detecting full-length protein

    • C-terminal region: Often accessible and useful for detecting truncated forms

    • Middle domain unique sequences: May offer optimal specificity

  • Epitope tagging alternative:

    • When direct antibody development proves challenging, consider creating yeast strains with epitope-tagged YLR456W

    • Use established tags (HA, Myc, FLAG) with validated commercial antibodies

    • Verify that tagging doesn't disrupt protein function through complementation assays

For definitive epitope mapping of successful antibodies, researchers should perform peptide competition assays or epitope mapping using peptide arrays to confirm binding to the intended regions. This approach follows the rigorous antibody characterization standards established by initiatives like YCharOS .

How can researchers distinguish between specific and non-specific signals when using YLR456W antibodies in different applications?

Distinguishing specific from non-specific signals requires systematic controls and validation:

  • Essential controls for all applications:

    • YLR456W knockout negative control (should show no signal)

    • Overexpression positive control (should show enhanced signal)

    • Secondary antibody-only control (to assess background)

    • Isotype control antibody (to assess non-specific binding)

  • Western blot validation:

    • Compare observed molecular weight with predicted size

    • Perform peptide competition assays

    • Test multiple antibodies targeting different epitopes

    • Evaluate signal reduction with siRNA/CRISPR in compatible systems

  • Immunofluorescence specificity assessment:

    • Compare staining pattern with literature or GFP-tagged constructs

    • Evaluate colocalization with known markers of predicted compartments

    • Assess signal changes during cell cycle progression or meiosis

    • Quantify signal-to-noise ratio across experimental conditions

  • Quantitative specificity metrics:

    • Calculate specificity score = (Signal in WT - Signal in KO) / Signal in WT

    • Implement machine learning approaches for pattern recognition in high-content imaging

    • Use statistical methods to differentiate signal from noise in quantitative applications

Researchers should document all validation steps according to the antibody validation guidelines similar to those used by YCharOS, which employs comprehensive knockout characterization for antibody validation . This rigorous approach is particularly important for poorly characterized proteins like YLR456W.

What computational approaches can help identify potential interaction partners of YLR456W using immunoprecipitation-mass spectrometry data?

Analyzing immunoprecipitation-mass spectrometry (IP-MS) data for YLR456W requires sophisticated computational approaches to distinguish true interactors from background:

  • Contaminant filtering:

    • Implement SAINT (Significance Analysis of INTeractome) algorithm

    • Compare against CRAPome database of common contaminants

    • Use label-free quantification to compare YLR456W IP vs. control IPs

  • Network analysis:

    • Integrate with existing yeast protein interaction databases

    • Apply MCL (Markov Clustering) to identify interaction clusters

    • Use GO term enrichment to identify biological processes enriched in the interactome

  • Dynamic interaction analysis:

    • Compare interactome changes across meiotic stages

    • Implement DIANA (Dynamic Interaction Analysis) for temporal interaction changes

    • Correlate with transcriptional data from meiosis studies

  • Visualization tools:

    • Cytoscape for network visualization

    • STRING-db for functional interaction prediction

    • Perseus for statistical analysis of proteomics data

  • Validation prioritization:

    • Rank potential interactors by specificity scores

    • Prioritize proteins involved in meiotic processes

    • Focus on proteins showing consistent enrichment across replicates

For YLR456W specifically, researchers should consider its potential role in meiotic cell division and prioritize interactions with known components of the meiotic machinery. Integration with existing yeast interactome data, such as physical and genetic interactions established via yeast two-hybrid assays and co-immunoprecipitation studies , can provide context for novel interactions discovered.

How should researchers interpret changes in YLR456W expression or localization during different stages of yeast meiosis?

Interpreting changes in YLR456W expression or localization during meiosis requires integration of multiple data types and careful experimental design:

  • Temporal expression profiling:

    • Perform time-course Western blot analysis during synchronized meiosis

    • Compare with RNA-seq data to identify post-transcriptional regulation

    • Create quantitative profiles of expression changes relative to established meiotic markers

  • Localization dynamics:

    • Use time-lapse immunofluorescence or live imaging with tagged constructs

    • Quantify subcellular distribution changes during meiotic progression

    • Co-stain with markers for key meiotic structures (synaptonemal complex, kinetochores, spindle)

  • Regulatory analysis:

    • Investigate potential regulation by meiotic transcription factors

    • Examine promoter regions for binding sites of known meiotic regulators like Ume6

    • Test dependency on meiotic kinases through inhibitor studies or kinase mutants

  • Functional context interpretation:

    • Correlate expression/localization changes with meiotic phenotypes in mutant strains

    • Compare patterns with known meiotic regulators

    • Develop mathematical models to predict function based on dynamics

  • Integration with global meiotic regulation:

    • Compare YLR456W dynamics with global meiotic transcriptome data

    • Position within existing regulatory networks of meiosis

    • Identify potential co-regulated genes for functional insights

The data should be interpreted in light of current understanding of the transcriptional landscape during yeast growth and sporulation . Researchers should pay particular attention to whether YLR456W exhibits patterns consistent with early, middle, or late meiotic genes, as this provides clues to its specific function within the meiotic program.

How can CRISPR-based approaches enhance the study of YLR456W function and antibody validation?

CRISPR technology offers powerful approaches for studying YLR456W and validating antibodies against it:

  • Genome editing applications:

    • Generate precise knockout strains for definitive antibody validation

    • Create epitope-tagged endogenous YLR456W for localization studies

    • Introduce point mutations to identify functional domains

    • Develop conditional degradation systems (AID/degron tags) for temporal control

  • CRISPR activation/repression:

    • Use CRISPRa to upregulate YLR456W expression for functional studies

    • Implement CRISPRi for temporal repression during specific meiotic stages

    • Create mosaic cultures with varied expression for competition assays

  • Advanced validation approaches:

    • Generate cell lines with modifications in specific epitopes to map antibody binding

    • Create control cell lines with humanized versions of YLR456W for cross-species validation

    • Develop CRISPR knock-in reporters (GFP/luciferase) for correlation with antibody signals

  • Screening applications:

    • Perform CRISPR screens to identify genetic interactors of YLR456W

    • Use pooled CRISPR libraries to discover pathways affecting YLR456W expression or localization

    • Combine with single-cell technologies for heterogeneity analysis

These CRISPR-based approaches provide more definitive validation than traditional methods while simultaneously generating tools for functional studies. The knockout validation approach aligns with the gold standard methods used by YCharOS for antibody characterization .

How might single-cell approaches revolutionize our understanding of YLR456W expression heterogeneity during meiosis?

Single-cell technologies offer unprecedented insights into cell-to-cell variability in YLR456W expression and function during meiosis:

  • Single-cell transcriptomics applications:

    • Perform scRNA-seq on synchronizing meiotic yeast populations

    • Identify subpopulations with differential YLR456W expression

    • Discover co-regulated gene networks at single-cell resolution

    • Map YLR456W to specific meiotic trajectories

  • Single-cell proteomics approaches:

    • Implement CyTOF with anti-YLR456W antibodies for protein-level quantification

    • Develop single-cell Western blot techniques for yeast

    • Apply proximity ligation assays for protein interaction studies at single-cell level

    • Use single-cell mass spectrometry for proteoform analysis

  • Imaging-based single-cell analysis:

    • Apply high-content imaging with YLR456W antibodies

    • Implement live-cell imaging with fluorescently tagged YLR456W

    • Quantify protein dynamics using FRAP or photoactivation approaches

    • Develop image-based transcriptomics (seqFISH) for correlated RNA/protein analysis

  • Computational integration:

    • Implement trajectory inference algorithms to map meiotic progression

    • Develop mathematical models of expression heterogeneity

    • Apply machine learning for phenotypic classification

    • Create multi-omics integration frameworks for comprehensive single-cell analysis

These approaches build upon established methodologies for quantitative yeast phenomics but extend to single-cell resolution. The combination of genetic manipulations, high-resolution imaging, and computational analysis will provide unprecedented insights into the role of YLR456W in meiotic processes and resolve potential heterogeneity that might be masked in population-level studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.